Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
How our clients use DrugPatentWatch
To get patent expiration dates and find out when generics plan to advertise and enter the market
— Pharmacist, USA
For drug patent information on drugs not available in Asia
— Pharmaceutical distribution, Singapore
To understand patent expirations of controlled substances
— Consulting, USA
To get reliable data on drug patent information
— CFO, Pharmaceuticals, Singapore
Patent information on sterle manufactured drugs and when they expire
— Regulatory affairs for a drug compounder, USA
DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 019847
is a drug marketed by Bayer Hlthcare, Novartis Pharms Corp, Bayer Pharms, Hikma Farmaceutica, Hospira, Claris, Lupin Ltd, Teva Pharms Usa, Fresenius Kabi Usa, Bedford Labs, Dr Reddys Labs Ltd, Actavis Labs Fl Inc, Sandoz, Anchen Pharms, Mylan Pharms Inc, Taro, Mylan, Barr, Carlsbad, Pliva, Apotex Inc, Teva, Nostrum Labs, Idt Australia Ltd, Unique Pharm Labs, Sun Pharm Inds Ltd, Teligent Pharma Inc, Akorn Inc, Hikma, Aurobindo Pharma, Fdc Ltd, Watson Labs Inc, Rising Pharms Inc, Ivax Sub Teva Pharms, Watson Labs, Apotex, Pharmaforce, Bedford, Teva Pharms, Acs Dobfar Info Sa, and Baxter Hlthcare, and is included in fifty-five NDAs. It is available from one supplier. There are eight patents protecting this drug and two Paragraph IV challenges. Additional details are available on the CIPRO profile page.
The generic ingredient in CIPRO is ciprofloxacin; dexamethasone. There are thirty-one drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ciprofloxacin; dexamethasone profile page.
Summary for NDA: 019847
Patents: 1 Therapeutic Class: Antibacterials
Formulation / Manufacturing: see details
Summary for product number 001
Active Rx/OTC/Discontinued: DISCN Dosage: INJECTABLE;INJECTION Strength 400MG/40ML (10MG/ML) Approval Date: Dec 26, 1990 TE: RLD: Yes
Summary for product number 002
Active Rx/OTC/Discontinued: DISCN Dosage: INJECTABLE;INJECTION Strength 200MG/20ML (10MG/ML) Approval Date: Dec 26, 1990 TE: RLD: Yes
Summary for product number 003
Active Rx/OTC/Discontinued: DISCN Dosage: INJECTABLE;INJECTION Strength 1200MG/120ML (10MG/ML) Approval Date: Dec 26, 1990 TE: RLD: No Expired Orange Book Patents for NDA: 019847
Bayer Hlthcare CIPRO ciprofloxacin INJECTABLE;INJECTION 019847-001 Dec 26, 1990 4,670,444*PED ► Subscribe
Bayer Hlthcare CIPRO ciprofloxacin INJECTABLE;INJECTION 019847-001 Dec 26, 1990 4,705,789*PED ► Subscribe
Bayer Hlthcare CIPRO ciprofloxacin INJECTABLE;INJECTION 019847-001 Dec 26, 1990 4,808,583*PED ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial
Complete Access Available with
How our clients use DrugPatentWatch
For information on products (NDAs and ANDAs) that I may be interested in developing, licensing or acquiring
— Executive, specialty pharmaceutical company, USA
To see which patents for drugs are expiring to do pipeline planning for our company
— Business development manager, South Africa
To get accurate and reliable patency status in Saudi Arabia and Middle East countries
— Director, business development, Saudi Arabia
To know about pharmaceutical patents and their expiration dates
— Pharmaceutical R&D, Venezuela
To find out patent expiration data for the Czech Republic
— Doctor, Czech Republic
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Related Products from thinkBiotech